MESSORI, MIRKO
 Distribuzione geografica
Continente #
NA - Nord America 337
AS - Asia 279
EU - Europa 181
Continente sconosciuto - Info sul continente non disponibili 1
Totale 798
Nazione #
US - Stati Uniti d'America 329
CN - Cina 271
IT - Italia 100
DE - Germania 23
FI - Finlandia 21
SE - Svezia 9
UA - Ucraina 9
CA - Canada 8
RU - Federazione Russa 8
GB - Regno Unito 6
IN - India 4
BE - Belgio 3
ID - Indonesia 2
EU - Europa 1
FR - Francia 1
IQ - Iraq 1
NL - Olanda 1
SA - Arabia Saudita 1
Totale 798
Città #
Chandler 132
Nanjing 66
Pavia 60
Beijing 52
Nanchang 40
Jacksonville 37
Wilmington 27
Lawrence 22
Medford 22
Princeton 22
Changsha 21
Shenyang 19
Hangzhou 18
Hebei 18
Ann Arbor 14
Jiaxing 13
Tianjin 10
Toronto 8
Busto Garolfo 6
Cameri 6
Woodbridge 6
Helsinki 5
Jinan 5
Dearborn 4
Fairfield 4
Brussels 3
San Francisco 3
Andover 2
Ashburn 2
Berlin 2
Brighton 2
Guangzhou 2
Norwalk 2
Redwood City 2
Bangalore 1
Boardman 1
Chicago 1
Cinisello Balsamo 1
Como 1
Dalmine 1
Des Moines 1
Groningen 1
Gunzenhausen 1
Houston 1
Kemerovo 1
Kunming 1
Mantova 1
Milan 1
Monselice 1
Ningbo 1
Orange 1
Redmond 1
San Benedetto del Tronto 1
San Mateo 1
Taiyuan 1
Trino 1
Vigevano 1
Zhengzhou 1
Totale 681
Nome #
Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas 69
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 55
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 55
Towards a Run-to-Run Adaptive Artificial Pancreas: In Silico Results 51
Automatic adaptation of basal therapy for Type 1 diabetic patients: A Run-to-Run approach 48
Postprandial glucose regulation via KNN meal classification in type 1 diabetes 47
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 44
A nonparametric approach for model individualization in an artificial pancreas 43
THE SOCIAL ACCEPTANCE OF FUTURE ARTIFICIAL PANCREAS TECHNOLOGY: PARENTS' PERCEPTIONS OF PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) 38
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas 38
Glucose-insulin model identified in free-living conditions for hypoglycaemia prevention 38
Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe 36
Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting 35
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 34
Parental evaluation of a telemonitoring service for children with Type 1 Diabetes 34
Individualized model predictive control for the artificial pancreas: In silico evaluation of closed-loop glucose control 33
MPC Model Individualization in Free-Living Conditions: A Proof-of-Concept Case Study 32
Model individualization for artificial pancreas 31
Il pancreas artificiale in età pediatrica: Prima esperienza Italiana 30
Model predictive control with integral action for artificial pancreas 29
Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial 25
Artificial Pancreas: from Control-to-Range to Control-to-Target 22
Totale 867
Categoria #
all - tutte 1892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201823 0000 00 013 7201
2018/201941 10200 12 131 1011
2019/2020302 8513732 22 74 136230
2020/202193 3106 511 218 361010
2021/2022161 3264 54 35 891894
2022/2023186 4839424 3138 20 0000
Totale 867